Similar to the effect of 2-DG, inhibiting mTOR with rapamycin decreased the production of IFN-γ and IL-17A in CD4+ T cells, further confirming the crucial role of CD28/PI3K/AKT/mTOR-mediated glycolysis in the pathogenesis of pSS. Here, IL17A is linked to peeling skin syndrome.